Brazilian consensus in gastric cancer: guidelines for gastric cancer in Brazil.

BACKGROUND In Brazil, gastric cancer is the fourth most common malignancy among men and sixth among women. The cause is multivariate and the risks are well known. It has prognosis and treatment defined by the location and staging of the tumor and number of lymph nodes resected and involved. AIM The Brazilian Consensus on Gastric Cancer promoted by ABCG was designed with the intention to issue guidelines that can guide medical professionals to care for patients with this disease. METHODS Were summarized and answered 43 questions reflecting consensus or not on diagnosis and treatment that may be used as guidance for its multidisciplinary approach. The method involved three steps. Initially, 56 digestive surgeons and related medical specialties met to formulate the questions that were sent to participants for answers on scientific evidence and personal experience. Summaries were presented, discussed and voted in plenary in two other meetings. They covered 53 questions involving: diagnosis and staging (six questions); surgical treatment (35 questions); chemotherapy and radiotherapy (seven questions) and anatomopathology, immunohistochemistry and perspective (five questions). It was considered consensus agreement on more than 70% of the votes in each item. RESULTS All the answers were presented and voted upon, and in 42 there was consensus. CONCLUSION It could be developed consensus on most issues that come with the care of patients with gastric cancer and they can be transformed in guidelines.

[1]  J. Ajani,et al.  Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  S. Kitano,et al.  Standard of practice on laparoscopic gastric cancer surgery in Korea and Japan: Experts’ survey , 2012, Asian journal of endoscopic surgery.

[3]  Shi-bin Yang,et al.  Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer. , 2011, World journal of gastroenterology.

[4]  Y. K. Park,et al.  General perioperative management of gastric cancer patients at high-volume centers , 2011, Gastric Cancer.

[5]  F. Bazzoli,et al.  Gastric cancer, Helicobacter pylori infection and other risk factors. , 2010, World journal of gastrointestinal oncology.

[6]  W. Kim,et al.  Stage Migration Effect on Survival in Gastric Cancer Surgery With Extended Lymphadenectomy: The Reappraisal of Positive Lymph Node Ratio as a Proper N-Staging , 2010, Annals of surgery.

[7]  Yoon-Koo Kang,et al.  Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial , 2010, The Lancet.

[8]  F. Sansonna,et al.  Subtotal gastrectomy with D2 dissection by minimally invasive surgery for distal adenocarcinoma of the stomach: results and 5-year survival , 2010, Surgical Endoscopy.

[9]  D. Park,et al.  Actual 3-year survival after laparoscopy-assisted gastrectomy for gastric cancer. , 2009, Archives of surgery.

[10]  Takaaki Masuda,et al.  Advantages of totally laparoscopic distal gastrectomy over laparoscopically assisted distal gastrectomy for gastric cancer , 2009, Surgical Endoscopy.

[11]  N. Nguyen,et al.  Comparison of laparoscopic and open gastrectomy for gastric cancer. , 2006, American journal of surgery.

[12]  A. Nashimoto,et al.  Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  T. Sano,et al.  Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan clinical oncology group study JCOG 0110-MF. , 2002, Japanese journal of clinical oncology.

[14]  T. Nakajima Gastric cancer treatment guidelines in Japan , 2002, Gastric Cancer.

[15]  Soo-Jeong Cho,et al.  Comparison of surgical performance and short-term clinical outcomes between laparoscopic and robotic surgery in distal gastric cancer. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  Chun-yu Huang,et al.  Prognosis of 980 patients with gastric cancer after surgical resection. , 2010, Chinese journal of cancer.

[17]  S. Choi,et al.  Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer. , 2001 .